Resource Center › Case Studies
Driving Global Compliance Through Structure and Partnership
In a complex merger, MedPro partnered with a global pharmaceutical company to unify four fragmented compliance systems into one scalable program without missing a reporting deadline.
Global pharmaceutical enterprise, 80,000 employees
MCR, Global Reporting
MCR
Post-merger transparency reporting across U.S. and European markets
The Challenge
When four major pharmaceutical manufacturers merged into a single global enterprise, each legacy company brought its own compliance program, vendor relationships and reporting processes. Unifying four fragmented systems across U.S. and international markets, while overseeing more than 20 third-party vendors, had to happen without missing a single reporting deadline.
The Result
Within months of implementation, the enterprise had centralized oversight of all systems and vendors, a single scalable transparency program supporting global operations and zero missed reporting obligations during one of the most complex integrations in the organization’s history.
“Our dedicated MedPro team typically responds the same day. MedPro provides timely, well-thought-out, high-value responses.”
Associate Director of Compliance
Inside the Full Story
Get the Full Story
The Solutions in This Story
Related resources
-
Provider Verification Beyond Compounding Pharmacy Onboarding
How current provider and facility information supports documented decisions from account setup through order fulfillment.
-
Where Prescriber Verification Fits in the Specialty Pharmacy Workflow
A practical look at verification checkpoints from prescription intake through dispensing and the value of current provider data at each stage.
-
7 Workflow Gaps That Slow Down Life Sciences Compliance Teams
As compliance responsibilities grow, small gaps between data, systems and teams can create extra manual work. Here are 7 places to look first and practical steps your team can take to strengthen the workflow.
-
Two International Disclosure Dates to Plan For
Colombia’s biannual value-transfer filing is due September 30, and Japan’s annual disclosure window follows each company’s fiscal year end.
